Global Cancer Treatment Drugs Sales Market Report 2017

Global Cancer Treatment Drugs Sales Market Report 2017

1 Cancer Treatment Drugs Market Overview

1.1 Product Overview and Scope of Cancer Treatment Drugs

1.2 Classification of Cancer Treatment Drugs by Product Category

1.2.1 Global Cancer Treatment Drugs Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global Cancer Treatment Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Chemotherapy

1.2.4 Targeted Therapy

1.2.5 Immunotherapy

1.2.6 Hormonal Therapy (Biologic Therapy)

1.2.7 Others

1.3 Global Cancer Treatment Drugs Market by Application/End Users

1.3.1 Global Cancer Treatment Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Blood Cancer

1.3.3 Breast Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Prostate Cancer

1.3.6 Respiratory/Lung Cancer

1.3.7 Other Cancers

1.4 Global Cancer Treatment Drugs Market by Region

1.4.1 Global Cancer Treatment Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States Cancer Treatment Drugs Status and Prospect (2012-2022)

1.4.3 China Cancer Treatment Drugs Status and Prospect (2012-2022)

1.4.4 Europe Cancer Treatment Drugs Status and Prospect (2012-2022)

1.4.5 Japan Cancer Treatment Drugs Status and Prospect (2012-2022)

1.4.6 Southeast Asia Cancer Treatment Drugs Status and Prospect (2012-2022)

1.4.7 India Cancer Treatment Drugs Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Cancer Treatment Drugs (2012-2022)

1.5.1 Global Cancer Treatment Drugs Sales and Growth Rate (2012-2022)

1.5.2 Global Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)

2 Global Cancer Treatment Drugs Competition by Players/Suppliers, Type and Application

2.1 Global Cancer Treatment Drugs Market Competition by Players/Suppliers

2.1.1 Global Cancer Treatment Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global Cancer Treatment Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global Cancer Treatment Drugs (Volume and Value) by Type

2.2.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)

2.3 Global Cancer Treatment Drugs (Volume and Value) by Region

2.3.1 Global Cancer Treatment Drugs Sales and Market Share by Region (2012-2017)

2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Region (2012-2017)

2.4 Global Cancer Treatment Drugs (Volume) by Application

3 United States Cancer Treatment Drugs (Volume, Value and Sales Price)

3.1 United States Cancer Treatment Drugs Sales and Value (2012-2017)

3.1.1 United States Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

3.1.2 United States Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

3.1.3 United States Cancer Treatment Drugs Sales Price Trend (2012-2017)

3.2 United States Cancer Treatment Drugs Sales Volume and Market Share by Players

3.3 United States Cancer Treatment Drugs Sales Volume and Market Share by Type

3.4 United States Cancer Treatment Drugs Sales Volume and Market Share by Application

4 China Cancer Treatment Drugs (Volume, Value and Sales Price)

4.1 China Cancer Treatment Drugs Sales and Value (2012-2017)

4.1.1 China Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

4.1.2 China Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

4.1.3 China Cancer Treatment Drugs Sales Price Trend (2012-2017)

4.2 China Cancer Treatment Drugs Sales Volume and Market Share by Players

4.3 China Cancer Treatment Drugs Sales Volume and Market Share by Type

4.4 China Cancer Treatment Drugs Sales Volume and Market Share by Application

5 Europe Cancer Treatment Drugs (Volume, Value and Sales Price)

5.1 Europe Cancer Treatment Drugs Sales and Value (2012-2017)

5.1.1 Europe Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

5.1.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

5.1.3 Europe Cancer Treatment Drugs Sales Price Trend (2012-2017)

5.2 Europe Cancer Treatment Drugs Sales Volume and Market Share by Players

5.3 Europe Cancer Treatment Drugs Sales Volume and Market Share by Type

5.4 Europe Cancer Treatment Drugs Sales Volume and Market Share by Application

6 Japan Cancer Treatment Drugs (Volume, Value and Sales Price)

6.1 Japan Cancer Treatment Drugs Sales and Value (2012-2017)

6.1.1 Japan Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

6.1.2 Japan Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

6.1.3 Japan Cancer Treatment Drugs Sales Price Trend (2012-2017)

6.2 Japan Cancer Treatment Drugs Sales Volume and Market Share by Players

6.3 Japan Cancer Treatment Drugs Sales Volume and Market Share by Type

6.4 Japan Cancer Treatment Drugs Sales Volume and Market Share by Application

7 Southeast Asia Cancer Treatment Drugs (Volume, Value and Sales Price)

7.1 Southeast Asia Cancer Treatment Drugs Sales and Value (2012-2017)

7.1.1 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Cancer Treatment Drugs Sales Price Trend (2012-2017)

7.2 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Players

7.3 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Type

7.4 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Application

8 India Cancer Treatment Drugs (Volume, Value and Sales Price)

8.1 India Cancer Treatment Drugs Sales and Value (2012-2017)

8.1.1 India Cancer Treatment Drugs Sales and Growth Rate (2012-2017)

8.1.2 India Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)

8.1.3 India Cancer Treatment Drugs Sales Price Trend (2012-2017)

8.2 India Cancer Treatment Drugs Sales Volume and Market Share by Players

8.3 India Cancer Treatment Drugs Sales Volume and Market Share by Type

8.4 India Cancer Treatment Drugs Sales Volume and Market Share by Application

9 Global Cancer Treatment Drugs Players/Suppliers Profiles and Sales Data

9.1 Roche (Switzerland)

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Cancer Treatment Drugs Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Roche (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Novartis (Switzerland)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Cancer Treatment Drugs Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Novartis (Switzerland) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Celgene (U.S.)

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Cancer Treatment Drugs Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Celgene (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Amgen (U.S.)

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Cancer Treatment Drugs Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Amgen (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Johnson & Johnson (U.S.)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Cancer Treatment Drugs Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Bristol-Myers Squibb (U.S.)

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Cancer Treatment Drugs Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Takeda (Japan)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Cancer Treatment Drugs Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Takeda (Japan) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Eli Lilly (U.S.)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Cancer Treatment Drugs Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Eli Lilly (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Pfizer (U.S.)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Cancer Treatment Drugs Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Pfizer (U.S.) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 AstraZeneca (Sweden)

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Cancer Treatment Drugs Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 AstraZeneca (Sweden) Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Astellas (Japan)

9.12 Sanofi (France)

9.13 Bayer (Germany)

9.14 Merck & Co. (U.S.)

9.15 Biogen Idec (U.S.)

9.16 Kyowa Hakko Kirin (Japan)

9.17 Otsuka (Japan)

9.18 Teva (Israel)

9.19 Eisai (Japan)

9.20 Merck KGaA (Germany)

9.21 Ipsen (France)

9.22 AbbVie (U.S.)

9.23 Gilead Sciences (U.S.)

10 Cancer Treatment Drugs Maufacturing Cost Analysis

10.1 Cancer Treatment Drugs Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Cancer Treatment Drugs

10.3 Manufacturing Process Analysis of Cancer Treatment Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Cancer Treatment Drugs Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Cancer Treatment Drugs Market Forecast (2017-2022)

14.1 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Cancer Treatment Drugs Price and Trend Forecast (2017-2022)

14.2 Global Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2017-2022)

14.3.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2017-2022)

14.3.3 Global Cancer Treatment Drugs Price Forecast by Type (2017-2022)

14.4 Global Cancer Treatment Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

Figure Product Picture of Cancer Treatment Drugs

Figure Global Cancer Treatment Drugs Sales Volume Comparison (K MT) by Type (2012-2022)

Figure Global Cancer Treatment Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Chemotherapy Product Picture

Figure Targeted Therapy Product Picture

Figure Immunotherapy Product Picture

Figure Hormonal Therapy (Biologic Therapy) Product Picture

Figure Others Product Picture

Figure Global Cancer Treatment Drugs Sales Comparison (K MT) by Application (2012-2022)

Figure Global Sales Market Share of Cancer Treatment Drugs by Application in 2016

Figure Blood Cancer Examples

Table Key Downstream Customer in Blood Cancer

Figure Breast Cancer Examples

Table Key Downstream Customer in Breast Cancer

Figure Gastrointestinal Cancer Examples

Table Key Downstream Customer in Gastrointestinal Cancer

Figure Prostate Cancer Examples

Table Key Downstream Customer in Prostate Cancer

Figure Respiratory/Lung Cancer Examples

Table Key Downstream Customer in Respiratory/Lung Cancer

Figure Other Cancers Examples

Table Key Downstream Customer in Other Cancers

Figure Global Cancer Treatment Drugs Market Size (Million USD) by Regions (2012-2022)

Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players Cancer Treatment Drugs Sales Volume (K MT) (2012-2017)

Table Global Cancer Treatment Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Global Cancer Treatment Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Cancer Treatment Drugs Sales Share by Players/Suppliers

Figure 2017 Cancer Treatment Drugs Sales Share by Players/Suppliers

Figure Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Cancer Treatment Drugs Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global Cancer Treatment Drugs Revenue Share by Players

Table 2017 Global Cancer Treatment Drugs Revenue Share by Players

Table Global Cancer Treatment Drugs Sales (K MT) and Market Share by Type (2012-2017)

Table Global Cancer Treatment Drugs Sales Share (K MT) by Type (2012-2017)

Figure Sales Market Share of Cancer Treatment Drugs by Type (2012-2017)

Figure Global Cancer Treatment Drugs Sales Growth Rate by Type (2012-2017)

Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global Cancer Treatment Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cancer Treatment Drugs by Type (2012-2017)

Figure Global Cancer Treatment Drugs Revenue Growth Rate by Type (2012-2017)

Table Global Cancer Treatment Drugs Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Global Cancer Treatment Drugs Sales Share by Region (2012-2017)

Figure Sales Market Share of Cancer Treatment Drugs by Region (2012-2017)

Figure Global Cancer Treatment Drugs Sales Growth Rate by Region in 2016

Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Cancer Treatment Drugs by Region (2012-2017)

Figure Global Cancer Treatment Drugs Revenue Growth Rate by Region in 2016

Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Cancer Treatment Drugs by Region (2012-2017)

Figure Global Cancer Treatment Drugs Revenue Market Share by Region in 2016

Table Global Cancer Treatment Drugs Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Global Cancer Treatment Drugs Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of Cancer Treatment Drugs by Application (2012-2017)

Figure Global Cancer Treatment Drugs Sales Market Share by Application (2012-2017)

Figure United States Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table United States Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table United States Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure United States Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table United States Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table United States Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure United States Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table United States Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table United States Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure United States Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Figure China Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table China Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table China Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure China Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table China Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table China Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure China Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table China Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table China Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure China Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Figure Europe Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table Europe Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table Europe Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table Europe Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table Europe Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Figure Japan Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table Japan Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table Japan Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table Japan Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table Japan Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Figure Southeast Asia Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Figure India Cancer Treatment Drugs Sales (K MT) and Growth Rate (2012-2017)

Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Cancer Treatment Drugs Sales Price (USD/MT) Trend (2012-2017)

Table India Cancer Treatment Drugs Sales Volume (K MT) by Players (2012-2017)

Table India Cancer Treatment Drugs Sales Volume Market Share by Players (2012-2017)

Figure India Cancer Treatment Drugs Sales Volume Market Share by Players in 2016

Table India Cancer Treatment Drugs Sales Volume (K MT) by Type (2012-2017)

Table India Cancer Treatment Drugs Sales Volume Market Share by Type (2012-2017)

Figure India Cancer Treatment Drugs Sales Volume Market Share by Type in 2016

Table India Cancer Treatment Drugs Sales Volume (K MT) by Application (2012-2017)

Table India Cancer Treatment Drugs Sales Volume Market Share by Application (2012-2017)

Figure India Cancer Treatment Drugs Sales Volume Market Share by Application in 2016

Table Roche (Switzerland) Basic Information List

Table Roche (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Roche (Switzerland) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Roche (Switzerland) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Roche (Switzerland) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Novartis (Switzerland) Basic Information List

Table Novartis (Switzerland) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis (Switzerland) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Novartis (Switzerland) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Novartis (Switzerland) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Celgene (U.S.) Basic Information List

Table Celgene (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Celgene (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Celgene (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Celgene (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Amgen (U.S.) Basic Information List

Table Amgen (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Amgen (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Amgen (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Amgen (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Johnson & Johnson (U.S.) Basic Information List

Table Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Johnson & Johnson (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Bristol-Myers Squibb (U.S.) Basic Information List

Table Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Bristol-Myers Squibb (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Takeda (Japan) Basic Information List

Table Takeda (Japan) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Takeda (Japan) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Takeda (Japan) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Takeda (Japan) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Eli Lilly (U.S.) Basic Information List

Table Eli Lilly (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Eli Lilly (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Eli Lilly (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Pfizer (U.S.) Basic Information List

Table Pfizer (U.S.) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer (U.S.) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure Pfizer (U.S.) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure Pfizer (U.S.) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table AstraZeneca (Sweden) Basic Information List

Table AstraZeneca (Sweden) Cancer Treatment Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales Growth Rate (2012-2017)

Figure AstraZeneca (Sweden) Cancer Treatment Drugs Sales Global Market Share (2012-2017

Figure AstraZeneca (Sweden) Cancer Treatment Drugs Revenue Global Market Share (2012-2017)

Table Astellas (Japan) Basic Information List

Table Sanofi (France) Basic Information List

Table Bayer (Germany) Basic Information List

Table Merck & Co. (U.S.) Basic Information List

Table Biogen Idec (U.S.) Basic Information List

Table Kyowa Hakko Kirin (Japan) Basic Information List

Table Otsuka (Japan) Basic Information List

Table Teva (Israel) Basic Information List

Table Eisai (Japan) Basic Information List

Table Merck KGaA (Germany) Basic Information List

Table Ipsen (France) Basic Information List

Table AbbVie (U.S.) Basic Information List

Table Gilead Sciences (U.S.) Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Treatment Drugs

Figure Manufacturing Process Analysis of Cancer Treatment Drugs

Figure Cancer Treatment Drugs Industrial Chain Analysis

Table Raw Materials Sources of Cancer Treatment Drugs Major Players in 2016

Table Major Buyers of Cancer Treatment Drugs

Table Distributors/Traders List

Figure Global Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Cancer Treatment Drugs Price (USD/MT) and Trend Forecast (2017-2022)

Table Global Cancer Treatment Drugs Sales Volume (K MT) Forecast by Regions (2017-2022)

Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions in 2022

Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2017-2022)

Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions in 2022

Figure United States Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure China Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Europe Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Cancer Treatment Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global Cancer Treatment Drugs Sales (K MT) Forecast by Type (2017-2022)

Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Type (2017-2022)

Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2017-2022)

Table Global Cancer Treatment Drugs Price (USD/MT) Forecast by Type (2017-2022)

Table Global Cancer Treatment Drugs Sales (K MT) Forecast by Application (2017-2022)

Figure Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources